Werewolf Therapeutics Inc (HOWL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 1,143 | 742 | 1,501 | 5,897 | 8,081 |
| Gross Profit | 1,143 | 742 | 1,501 | 5,897 | 8,081 |
| Operating Expenses | 20,103 | 17,904 | 14,463 | 15,148 | 14,148 |
| Operating Income | -18,960 | -17,162 | -12,962 | -9,251 | -6,067 |
| Interest Expense | 1,142 | 1,003 | 1,010 | 1,002 | 955 |
| Other Income | 2,853 | 1,972 | 1,969 | 1,968 | 1,924 |
| Pre-tax Income | -17,249 | -16,193 | -12,003 | -8,285 | -5,098 |
| Net Income Continuous | -17,249 | -16,193 | -12,003 | -8,285 | -5,098 |
| Net Income | $-17,249 | $-16,193 | $-12,003 | $-8,285 | $-5,098 |
| EPS Basic Total Ops | -0.40 | -0.39 | -0.34 | -0.23 | -0.14 |
| EPS Basic Continuous Ops | -0.40 | -0.39 | -0.33 | -0.23 | -0.14 |
| EPS Diluted Total Ops | -0.43 | -0.39 | -0.34 | -0.23 | -0.14 |
| EPS Diluted Continuous Ops | -0.39 | -0.39 | -0.33 | -0.23 | -0.14 |
| EPS Diluted Before Non-Recurring Items | -0.43 | -0.39 | -0.33 | N/A | N/A |
| EBITDA(a) | $-18,506 | $-16,698 | $-12,502 | $-8,806 | $-5,633 |